Skip to nav Skip to content
Yossi  Schwartz

Yossi Schwartz, MD, MPH

Specialty: Pathology

Program: Pathology

  • Overview

    Dr. Schwartz received his MD from Technion-Israel Institute of Technology, Haifa, Israel, and his MPH from Columbia University, Mailman School of Public Health, New York. He completed an Internal Medicine Residency at Morristown Memorial Hospital, Affiliate of Columbia University, College of Physician and Surgeons, Morristown, New Jersey. Dr. Schwartz completed a Hematology Fellowship at Tel Aviv Sourasky Medical Center, Affiliate of Sackler School of Medicine, Tel Aviv University, Israel; a Research Fellowship, Hematopoietic Immunochemistry Laboratory, at Memorial Sloan Kettering Cancer Center; and a Transfusion Medicine Fellowship at New York Blood Center. In 2004, he joined the faculty at Columbia University, Vagelos College of Physicians and Surgeons, as an Assistant Professor and was promoted to Associate Professor in 2010 and Professor in 2015. Dr. Schwartz joins us from Icahn School of Medicine at Mount Sinai, where he was a Professor in the Department of Pathology, Molecular and Cell-Based Medicine. Dr. Schwartz’s vision for excellence in Transfusion Medicine (Blood Banking, Tissue Banking, Apheresis and Cellular Therapy) lies in building a bridge between the contexts in which it is practiced. He plans to strengthen collaboration, streamline communication, and enhance standardization between the patient-facing needs of blood and tissue products and utilization and laboratory operations, and he is committed to service optimization.

  • Publications

    • Lee W, Heo S, Stewart R, Wu X, Fong KC, Son JY, Sabath B, Braun D, Park JY, Kim YC, Lee JP, Schwartz J, Kim H, Dominici F, Bell ML. Associations between greenness and kidney disease in Massachusetts: The US Medicare longitudinal cohort study. Environ Int. 2023 Mar.173:107844. Pubmedid: 36841189.
    • Ramsey G, Park YA, Eder AF, Bobr A, Karafin MS, Karp JK, King KE, Pagano MB, Schwartz J, Szczepiorkowski ZM, Souers RJ, Thomas L, Delaney M. Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services. Arch Pathol Lab Med. 2023 Jan.147(1):71-78. Pubmedid: 35486492.
    • Karafin MS, DeSimone RA, Dvorak J, Metcalf RA, Pagano MB, Park YA, Schwartz J, Souers RJ, Szczepiorkowski ZM, Uhl L, Ramsey G. Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use. Arch Pathol Lab Med. 2023 Feb. Pubmedid: 36730468.
    • Treml A, Joshi SA, Stephens LD, Zantek ND, Tanhehco YC, Mason HM, Li Y, Srivaths P, Mattiazzi AD, Schwartz J, Wehrli G. Apheresis medicine education during the early phase of the COVID-19 pandemic. Transfusion. 2023 Aug.63(8):1580-1589. Pubmedid: 37421258.
    • Thibodeaux SR, Aqui NA, Park YA, Schneiderman J, Su LL, Winters JL, Zubair AC, Schwartz J, Liu HD. Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies. J Clin Apher. 2022 Jun.37(3):223-236. Pubmedid: 35085413.
    • Gammon RR, Al-Mozain N, Auron M, Bocquet C, Clem S, Gupta GK, Hensch L, Klein N, Lea NC, Mandal S, Pelletier P, Resheidat A, Schwartz J. Transfusion therapy of neonatal and paediatric patients: They are not just little adults. Transfus Med. 2022 Dec.32(6):448-459. Pubmedid: 36207985.
    • Hod EA, Brittenham GM, Bitan ZC, Feit Y, Gaelen JI, La Carpia F, Sandoval LA, Zhou AT, Soffing M, Mintz A, Schwartz J, Eng C, Scotto M, Caccappolo E, Habeck C, Stern Y, McMahon DJ, Kessler DA, Shaz BH, Francis RO, Spitalnik SL. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being. Blood. 2022 Dec.140(25):2730-2739. Pubmedid: 36069596. Pmcid: PMC9837440.
    • Alseraihy A, McGrath E, Niederwieser D, Chabannon C, Szer J, Mohty M, Kharfan-Dabaja MA, Orchard K, Schwartz J, Rasheed W, Koh M, Kröger N, Kodera Y, Fakih RE, Worel N, Manson L, Rintala T, Tabakhi A, Savani B, Gergis U, Sureda A, Eldridge PW, Yakoub-Agha I, Hamadani M, Weisdorf D, Greinix H, Aljurf M. Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy. Transplant Cell Ther. 2022 Aug.28(8):455-462. Pubmedid: 35413459.
    • DeSimone RA, Costa VA, Kane K, Sepulveda JL, Ellsworth GB, Gulick RM, Zucker J, Sobieszcyk ME, Schwartz J, Cushing MM. Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve. Transfusion. 2021 Mar.61(3):692-698. Pubmedid: 33215718. Pmcid: PMC7753518.
    • O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, João E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 Jul.131(13). Pubmedid: 33974559. Pmcid: PMC8245169.
    • Tanhehco YC, Schwartz J. Cellular and gene therapy for the treatment of hematologic diseases and solid tumors: The dawn of a new era. Transfus Apher Sci. 2021 Feb.60(1):103055. Pubmedid: 33551271.
    • Karafin MS, Becker JL, Berg M, DeSimone RA, Draper NL, Hudgins J, Metcalf RA, Pagano MB, Park YA, Rossmann SN, Schwartz J, Souers R, Thomas L, Uhl L, Ramsey GE. Heterogeneity in Approaches for Switching From Universal to Patient ABO Type-Specific Blood Components During Massive Hemorrhage. Arch Pathol Lab Med. 2021 Dec.145(12):1499-1504. Pubmedid: 33720316.
    • Balogun RA, Sanchez AP, Klingel R, Witt V, Aqui N, Meyer E, Padmanabhan A, Pham HP, Schneiderman J, Schwartz J, Wu Y, Zantek ND, Connelly-Smith L, Dunbar NM. Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis. J Clin Apher. 2020 Sep.35(5):493-499. Pubmedid: 32770558.
    • Tanhehco YC, Schwartz J. How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. Transfusion. 2020 Sep.60(9):1905-1909. Pubmedid: 32583465. Pmcid: PMC7361330.
    • Vossoughi S, Fischkoff K, DeSimone RA, Schwartz J. Blood stewardship: conservation and supply of blood components during the severe acute respiratory syndrome coronavirus 2 pandemic. Transfusion. 2020 Sep.60(9):2156-2158. Pubmedid: 32672371. Pmcid: PMC7404962.
    • Pagano MB, Treml A, Stephens LD, Joshi S, Li Y, Lopez-Plaza I, Poyyapakkam S, Schwartz J, Tanhehco Y, Zantek ND. Entrustable professional activities for apheresis medicine education. Transfusion. 2020 Oct.60(10):2432-2440. Pubmedid: 32757215.
    • Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. Bone Marrow Transplant. 2020 Nov.55(11):2121-2131. Pubmedid: 32355289. Pmcid: PMC7606543.
    • Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun.21(1):499. Pubmedid: 32513308. Pmcid: PMC7276974.
    • Annen K, Zubair A, Schwartz E, Schwartz J, Szczepiorkowski ZM. What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR-T therapy. J Clin Apher. 2020 Jun.35(3):234-235. Pubmedid: 32186782.
    • Vossoughi S, Schwartz J. Non-evidence-based platelet transfusions for protocol eligibility. Cytotherapy. 2020 Jul.22(7):343. Pubmedid: 32560827. Pmcid: PMC7196410.
    • Ipe TS, Raval JS, Fernando LP, Gokhale A, Jacquot C, Johnson AD, Kim HC, Monis GF, Mo YD, Morgan SM, Pagano MB, Pham HP, Sanford K, Schmidt AE, Schwartz J, Waldman A, Webb J, Winters JL, Wu Y, Yamada C, Wong ECC. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee. J Clin Apher. 2020 Jan.35(1):25-32. Pubmedid: 31705563.
    • Vossoughi S, Winters JL, Burgstaler EA, Schwartz J. The ABC's of disaster management: Managing apheresis operations during the SARS-CoV-2 pandemic. J Clin Apher. 2020 Aug.35(4):243-245. Pubmedid: 32604469. Pmcid: PMC7361734.
    • Bertolone L, Shin HK, Stefanoni D, Baek JH, Gao Y, Morrison EJ, Nemkov T, Thomas T, Francis RO, Hod EA, Zimring JC, Yoshida T, Karafin M, Schwartz J, Hudson KE, Spitalnik SL, Buehler PW, D'Alessandro A. ZOOMICS: Comparative Metabolomics of Red Blood Cells From Old World Monkeys and Humans. Front Physiol. 2020.11:593841. Pubmedid: 33192610. Pmcid: PMC7645159.
    • Cushing MM, Pagano MB, Jacobson J, Schwartz J, Grossman BJ, Kleinman S, Han MA, Cohn CS. Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Transfusion. 2019 Sep.59(9):2974-2988. Pubmedid: 31268584.
    • Pham HP, Schwartz J. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Presse Med. 2019 Nov.48(11 Pt 2):338-346. Pubmedid: 31679897.
    • Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019 Jun.34(3):171-354. Pubmedid: 31180581.
    • Pham HP, Staley EM, Schwartz J. Therapeutic plasma exchange - A brief review of indications, urgency, schedule, and technical aspects. Transfus Apher Sci. 2019 Jun.58(3):237-246. Pubmedid: 31085053.
    • Francis RO, Mahajan S, Rapido F, La Carpia F, Soffing M, Divgi C, Yeh R, Mintz A, Leslie L, Agrest I, Karafin MS, Ginzburg Y, Shaz BH, Spitalnik SL, Schwartz J, Thomas T, Fu X, Amireault P, Buffet P, Zimring JC, D'Alessandro A, Hod EA. Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method. Transfusion. 2019 Jul.59(7):2264-2275. Pubmedid: 31002399.
    • Bitan ZC, Zhou A, McMahon DJ, Kessler D, Shaz BH, Caccappolo E, Schwartz J, Francis RO, Brittenham GM, Spitalnik SL, Hod EA. Donor Iron Deficiency Study (DIDS): protocol of a study to test whether iron deficiency in blood donors affects red blood cell recovery after transfusion. Blood Transfus. 2019 Jul.17(4):274-280. Pubmedid: 31385800. Pmcid: PMC6683873.
    • Vossoughi S, Schwartz J, Stotler B. Management of immunotherapy products in the blood bank. Transfusion. 2019 Dec.59(12):3800-3801. Pubmedid: 31802510.
    • Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB. Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee. Transfusion. 2019 Aug.59(8):2733-2748. Pubmedid: 31148175.
    • Vossoughi S, Parker-Jones S, Schwartz J, Stotler B. Provider trends in paediatric and adult transfusion reaction reporting. Vox Sang. 2019 Apr.114(3):232-236. Pubmedid: 30734306.
    • Connelly-Smith L, Tanhehco YC, Chhibber V, Delaney M, Eichbaum Q, Fernandez C, Joshi S, Schwartz J, Linenberger M. Choosing Wisely for apheresis. J Clin Apher. 2018 Oct.33(5):576-579. Pubmedid: 30325055.
    • Balogun RA, Schwartz J, Dunbar N, Padmanabhan A. In response to Peedin and Karp, "The definition of severe systemic lupus erythematosus needs clarification in the next ASFA guidelines". J Clin Apher. 2018 Oct.33(5):624. Pubmedid: 30187957.
    • DeSimone RA, Leung WK, Schwartz J. Transfusion Medicine in a Multidisciplinary Approach to Morbidly Adherent Placenta: Preparing for and Preventing the Worst. Transfus Med Rev. 2018 Oct.32(4):244-248. Pubmedid: 30025661.
    • Godbey EA, Schwartz J. 'Massive transfusion protocols and the use of tranexamic acid'. Curr Opin Hematol. 2018 Nov.25(6):482-485. Pubmedid: 30124475.
    • Pham HP, Schwartz J. Adding neonatal hyperbilirubinemia/bilirubin encephalopathy to the American Society for Apheresis Guidelines on Therapeutic Apheresis. J Clin Apher. 2018 Jun.33(3):449. Pubmedid: 29193228.
    • Pham HP, Raju D, Schwartz J. Do we have enough evidence for recommending therapeutic plasma exchange for patients with natalizumab-associated progressive multifocal leukoencephalopathy?. J Clin Apher. 2018 Jun.33(3):452-453. Pubmedid: 29446163.
    • Tanhehco YC, Schwartz J. How we manage clinical trials in the cellular therapy laboratory. Transfusion. 2018 Jan.58(1):8-15. Pubmedid: 28940293.
    • Cushing MM, Kelley J, Klapper E, Friedman DF, Goel R, Heddle NM, Hopkins CK, Karp JK, Pagano MB, Perumbeti A, Ramsey G, Roback JD, Schwartz J, Shaz BH, Spinella PC, Cohn CS, Cohn CS, Cushing MM, Kelley J, Klapper E. Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. Transfusion. 2018 Apr.58(4):1065-1075. Pubmedid: 29520794.
    • Szpirt W, Schwartz J. Opponent's comments. Nephrol Dial Transplant. 2017 Sep.32(9):1460. Pubmedid: 29059398.
    • Szpirt W, Schwartz J. Con: High-volume plasma exchange application in nephrology and beyond. Nephrol Dial Transplant. 2017 Sep.32(9):1461-1463. Pubmedid: 29059399.
    • Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H, Schwartz J, Eisenberger A, Soffing M, Yeh R, Divgi C, Ginzburg YZ, Shaz BH, Sheth S, Francis RO, Spitalnik SL, Hod EA. Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest. 2017 Jan.127(1):375-382. Pubmedid: 27941245. Pmcid: PMC5199711.
    • Yamada C, Pham HP, Wu Y, Cooling L, Kim HC, Morgan S, Schwartz J, Winters JL, Wong EC. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis. J Clin Apher. 2017 Feb.32(1):5-11. Pubmedid: 26946363.
    • Pagano MB, Wehrli G, Cloutier D, Galvin Karr E, Lopez-Plaza I, Schwartz J, Andrzejewski C, Winters JL, Wong EC, Wu Y, Zantek ND. Apheresis Medicine education in the United States of America: State of the discipline. Transfus Apher Sci. 2017 Feb.56(1):1-5. Pubmedid: 28089411.
    • Schwartz J. Significant changes in the 6th edition of FACT-JACIE standards affecting apheresis facilities. Transfus Apher Sci. 2017 Feb.56(1):26-27. Pubmedid: 28094109.
    • Weisberg SP, Staley EM, Williams LA, Pham HP, Bachegowda LS, Cheng YH, Schwartz J, Shaz BH. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation. Arch Pathol Lab Med. 2017 Dec.141(12):1705-1711. Pubmedid: 28849943.
    • DeSimone RA, Schwartz J, Schneiderman J. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations. J Clin Apher. 2017 Dec.32(6):543-552. Pubmedid: 28304115.
    • DeSimone RA, Wontakal SN, Lyashchenko AK, Schwartz J. Acute mechanical hemolysis as a complication of extracorporeal photopheresis in a low-weight child. J Clin Apher. 2017 Dec.32(6):571-573. Pubmedid: 27891662.
    • Okerberg CK, Williams LA, Kilgore ML, Kim CH, Marques MB, Schwartz J, Pham HP. Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation. Vox Sang. 2016 Oct.111(3):292-298. Pubmedid: 27248502.
    • Pham HP, Schwartz J. New apheresis indications in hematological disorders. Curr Opin Hematol. 2016 Nov.23(6):581-587. Pubmedid: 27518929.
    • Tanhehco YC, Weisberg S, Schwartz J. Pancreatic islet autotransplantation for nonmalignant and malignant indications. Transfusion. 2016 Mar.56(3):761-770. Pubmedid: 26593636.
    • Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016 Jun.31(3):149-162. Pubmedid: 27322218.
    • Staley EM, Schwartz J, Pham HP. An update on ABO incompatible hematopoietic progenitor cell transplantation. Transfus Apher Sci. 2016 Jun.54(3):337-344. Pubmedid: 27211814.
    • Pham HP, Schwartz J, Cooling L, Hofmann JC, Kim HC, Morgan S, Pagano MB, Schneiderman J, Winters JL, Yamada C, Wong EC, Wu Y. Report of the ASFA apheresis registry study on Wilson's disease. J Clin Apher. 2016 Feb.31(1):11-15. Pubmedid: 26275240. Pmcid: PMC4713324.
    • O'Leary MF, Dunbar NM, Kim HC, Draper NL, Linenberger M, Schwartz J, Miller Y, Murtaugh A, West FB, Fernando LP, Park YA. Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommittee. J Clin Apher. 2016 Dec.31(6):529-534. Pubmedid: 26762291.
    • Pham HP, Schwartz J. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis. Transfusion. 2015 Oct.55(10):2306-2311. Pubmedid: 26267387.
    • Tanhehco YC, Schwartz J, Linenberger ML. Defining the quality of hematopoietic stem cell products: the devil is in the details. Transfusion. 2015 Oct.55(10):2300-2303. Pubmedid: 26459961.
    • Stotler BA, Schwartz J. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Transfusion. 2015 Nov.55(11):2547-2550. Pubmedid: 26094894.
    • Keever-Taylor CA, Slaper-Cortenbach I, Celluzzi C, Loper K, Aljurf M, Schwartz J, Mcgrath E, Eldridge P. Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation. Cytotherapy. 2015 Dec.17(12):1831-1844. Pubmedid: 26455277.
    • Pham HP, Sireci AN, Kim CH, Schwartz J. Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure. Clin Appl Thromb Hemost. 2014 Sep.20(6):607-614. Pubmedid: 24642632.
    • Pham HP, Kim CH, Schwartz J. Phenotypically matched vs. traditional screen method for preparing red blood cell units in patients with abnormal placentation: a decision analysis approach. Vox Sang. 2014 Nov.107(4):399-406. Pubmedid: 25040228.
    • McGuinn C, Geyer MB, Jin Z, Garvin JH, Satwani P, Bradley MB, Bhatia M, George D, Duffy D, Morris E, van de Ven C, Schwartz J, Baxter-Lowe LA, Cairo MS. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia. Pediatr Blood Cancer. 2014 Jul.61(7):1289-1294. Pubmedid: 24623601.
    • Bhatia M, Jin Z, Baker C, Geyer MB, Radhakrishnan K, Morris E, Satwani P, George D, Garvin J, Del Toro G, Zuckerman W, Lee MT, Licursi M, Hawks R, Smilow E, Baxter-Lowe LA, Schwartz J, Cairo MS. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant. 2014 Jul.49(7):913-920. Pubmedid: 24797180.
    • Pham HP, Hsu SX, Parker-Jones S, Samstein B, Diuguid D, Schwartz J. Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience. Vox Sang. 2014 Jan.106(1):75-82. Pubmedid: 23815226.
    • Shaz BH, Schwartz J, Winters JL. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures. Transfusion. 2014 Jan.54(1):17-25. Pubmedid: 24261606.
    • Shaz BH, Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Szczepiorkowski ZM, Williams ME, Wu Y, Linenberger ML. American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia. Clin Infect Dis. 2014 Jan.58(2):302-303. Pubmedid: 24092801.
    • Pham HP, Schwartz J, Tanhehco Y. Therapeutic plasma exchange in a patient with erythropoietic protoporphyria status post orthothopic liver transplantation as a bridge to hematopoietic stem cell transplantation. J Clin Apher. 2014 Dec.29(6):341-342. Pubmedid: 24890923.
    • Cohn CS, Stubbs J, Schwartz J, Francis R, Goss C, Cushing M, Shaz B, Mair D, Brantigan B, Heaton WA. A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion. 2014 Aug.54(8):1927-1934. Pubmedid: 24735171.
    • Delaney M, Capocelli KE, Eder AF, Schneiderman J, Schwartz J, Sloan SR, Wong EC, Kim HC. An international survey of pediatric apheresis practice. J Clin Apher. 2014 Apr.29(2):120-126. Pubmedid: 24105856.
    • Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013 Jul.28(3):145-284. Pubmedid: 23868759.
    • Le Gall JB, Milone MC, Waxman IM, Shaw LM, Harrison L, Duffy D, van de Ven C, Militano O, Geyer MB, Morris E, Bhatia M, Satwani P, George D, Garvin JH, Bradley MB, Schwartz J, Baxter-Lowe LA, Cairo MS. The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients. Bone Marrow Transplant. 2013 Jan.48(1):19-25. Pubmedid: 22684047.
    • Raciti PM, Francis RO, Spitalnik PF, Schwartz J, Jhang JS. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood. J Clin Apher. 2013 Aug.28(4):325-329. Pubmedid: 23450789.
    • Satwani P, Jin Z, Duffy D, Morris E, Bhatia M, Garvin JH, George D, Bradley MB, Harrison L, Petrillo K, Schwartz J, Foley S, Hawks R, Baxter-Lowe LA, Cairo MS. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Biol Blood Marrow Tr. 2013 Apr.19(4):552-561. Pubmedid: 23253557.
    • Marshall CS, Andrzejewski C, Carey PM, Crookston KP, Li Y, Lopez-Plaza I, Sachais BS, Schwartz J, Winters JL, Wong EC, Wu Y. Milestones for Apheresis education. J Clin Apher. 2012 Nov.27(5):242-246. Pubmedid: 22778041.
    • Pham HP, Rogoza K, Stotler B, Duffy D, Parker-Jones S, Ginzburg Y, Bhatia M, Cairo M, Schwartz J. Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience. J Pediat Hematol Onc. 2012 Nov.34(8):e332-e336. Pubmedid: 22858567.
    • Arinsburg SA, Skerrett DL, Karp JK, Ness PM, Jhang J, Padmanabhan A, Gibble J, Schwartz J, King KE, Cushing MM. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI. Transfusion. 2012 May.52(5):946-952. Pubmedid: 22060800.
    • Jhang JS, Schwartz J. Phlebotomy or bloodletting: from tradition to evidence-based medicine. Transfusion. 2012 Mar.52(3):460-462. Pubmedid: 22404509.
    • George D, El-Mallawany NK, Jin Z, Geyer M, Della-Latta P, Satwani P, Garvin JH, Bradley MB, Bhatia M, van de Ven C, Morris E, Schwartz J, Cairo MS. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Brit J Haematol. 2012 Jan.156(1):99-108. Pubmedid: 22008222.
    • Satwani P, Bhatia M, Garvin JH, George D, Dela Cruz F, Le Gall J, Jin Z, Schwartz J, Duffy D, van de Ven C, Foley S, Hawks R, Morris E, Baxter-Lowe LA, Cairo MS. A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regim. Biol Blood Marrow Tr. 2012 Feb.18(2):324-329. Pubmedid: 22079471.
    • Dickson MN, Amar L, Hill M, Schwartz J, Leonard EF. A scalable, micropore, platelet rich plasma separation device. Biomed Microdevices. 2012 Dec.14(6):1095-1102. Pubmedid: 22811077.
    • Pham HP, Patel N, Semedei-Pomales M, Bhatia M, Schwartz J. The use of plerixafor in hematopoietic progenitor cell collection in pediatric patients: a single center experience. Cytotherapy. 2012 Apr.14(4):467-472. Pubmedid: 22339604.
    • Geyer MB, Ricci AM, Jacobson JS, Majzner R, Duffy D, Van de Ven C, Ayello J, Bhatia M, Garvin JH, George D, Satwani P, Harrison L, Morris E, Semidei-Pomales M, Schwartz J, Alobeid B, Baxter-Lowe LA, Cairo MS. T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients. Brit J Haematol. 2012 Apr.157(2):205-219. Pubmedid: 22313507.
    • Schwartz J. Evidence-based guideline update: plasmapheresis in neurologic disorders. Neurology. 2011 Oct.77(17):e105-e106. Pubmedid: 22135818.
    • Geyer MB, Jacobson JS, Freedman J, George D, Moore V, van de Ven C, Satwani P, Bhatia M, Garvin JH, Bradley MB, Harrison L, Morris E, Della-Latta P, Schwartz J, Baxter-Lowe LA, Cairo MS. A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. Brit J Haematol. 2011 Oct.155(2):218-234. Pubmedid: 21848882. Pmcid: PMC3188698.
    • Marques MB, Schwartz J. Update on extracorporeal photopheresis in heart and lung transplantation. J Clin Apher. 2011 Nov.26(3):146-151. Pubmedid: 21647952.
    • Stotler BA, Reich-Slotky R, Schwartz J, Inabnet WB, Lee J, Wu F, Della-Latta P, Jhang JS. Quality monitoring of microbial contamination of cryopreserved parathyroid tissue. Cell Tissue Bank. 2011 May.12(2):111-116. Pubmedid: 20058088.
    • Daniel-Johnson J, Schwartz J. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?. Transfusion. 2011 Jun.51(6):1143-1149. Pubmedid: 21382041.
    • Styczynski J, Tallamy B, Waxman I, van de Ven C, Milone MC, Shaw LM, Harrison L, Morris E, Satwani P, Bhatia M, George D, Bradley MB, Garvin JH, Schwartz J, Baxter-Lowe LA, Cairo MS. A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents. Bone Marrow Transplant. 2011 Jun.46(6):790-799. Pubmedid: 20818441.
    • Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. Hum Immunol. 2011 Jan.72(1):5-10. Pubmedid: 20971146.
    • Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S, Yazdanbakhsh K. Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol. 2011 Dec.86(12):1001-1006. Pubmedid: 21953592. Pmcid: PMC3618679.
    • Hod EA, Brittenham GM, Billote GB, Francis RO, Ginzburg YZ, Hendrickson JE, Jhang J, Schwartz J, Sharma S, Sheth S, Sireci AN, Stephens HL, Stotler BA, Wojczyk BS, Zimring JC, Spitalnik SL. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood. 2011 Dec.118(25):6675-6682. Pubmedid: 22021369. Pmcid: PMC3242722.
    • Pham HP, Daniel-Johnson JA, Stotler BA, Stephens H, Schwartz J. Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis. J Clin Apher. 2011 Dec.26(6):320-325. Pubmedid: 21898576.
    • Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011 Dec.51(12):2627-2633. Pubmedid: 21658046.
    • Neier M, Jin Z, Kleinman C, Baldinger L, Bhatia M, Silver E, van de Ven C, Morris E, Satwani P, George D, Garvin J, Bradley MB, Schwartz J, Cairo MS. Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease. Bone Marrow Transplant. 2011 Apr.46(4):529-538. Pubmedid: 20581882.
    • Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010 Oct.25(3):83-177. Pubmedid: 20568098.
    • Manga K, Serban G, Schwartz J, Slotky R, Patel N, Fan J, Bai X, Chari A, Savage D, Suciu-Foca N, Colovai AI. Increased adenosine triphosphate production by peripheral blood CD4+ cells in patients with hematologic malignancies treated with stem cell mobilization agents. Hum Immunol. 2010 Jul.71(7):652-658. Pubmedid: 20381567.
    • Ho EK, Vlad G, Colovai AI, Vasilescu ER, Schwartz J, Sondermeijer H, Burke E, Marboe CC, Itescu S, Suciu-Foca N, Mancini D. Alloantibodies in heart transplantation. Hum Immunol. 2009 Oct.70(10):825-829. Pubmedid: 19555730.
    • Padmanabhan A, Ratner LE, Jhang JS, Duong JK, Markowitz GS, Vasilescu ER, Crew RJ, Schwartz J. Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: a single-center experience. Transplantation. 2009 Jun.87(12):1889-1896. Pubmedid: 19543070.
    • Waxman IM, Militano O, Baldinger L, Roman E, Qualter E, Morris E, Garvin J, Bradley MB, Bhatia M, Satwani P, George D, Del Toro G, Hawks R, Wolownik K, Foley S, Cheung YK, Schwartz J, van de Ven C, Baxter-Lowe LA, Cairo MS. Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. Pediatr Transplant. 2009 Jun.13(4):464-474. Pubmedid: 18785912.
    • Reich-Slotky R, Schwartz J. Transfusion Medicine Illustrated. The importance of visually inspecting cord blood units upon receipt. Transfusion. 2009 Feb.49(2):204-205. Pubmedid: 19389206.
    • Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Tr. 2009 Dec.15(12):1587-1595. Pubmedid: 19896083.
    • Padmanabhan A, Reich-Slotky R, Jhang JS, Dael S, Crowder T, Colovai AI, Schwartz J. Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest. Vox Sang. 2009 Aug.97(2):153-159. Pubmedid: 19392781.
    • Reich-Slotky R, Patel N, Schwartz J. Transfusion medicine illustrated. Solving an unusual clotting event during thawing of peripheral blood hematopoietic progenitor cell product. Transfusion. 2009 Apr.49(4):622-623. Pubmedid: 19335377.
    • Padmanabhan A, Schwartz J, Spitalnik SL. Transfusion therapy in postpartum hemorrhage. Semin Perinatol. 2009 Apr.33(2):124-127. Pubmedid: 19324242.
    • Reich-Slotky R, Wu F, Della-Latta P, Savage DG, Schwartz J. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products. Transfusion. 2008 Nov.48(11):2409-2413. Pubmedid: 18657076.
    • Patel VL, Schwartz J, Bussel JB. The effect of anti-CD40 ligand in immune thrombocytopenic purpura. Brit J Haematol. 2008 May.141(4):545-548. Pubmedid: 18341638.
    • Reich-Slotky R, Colovai AI, Semidei-Pomales M, Patel N, Cairo M, Jhang J, Schwartz J. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Vox Sang. 2008 May.94(4):351-357. Pubmedid: 18179677.
    • Hod E, Schwartz J. Platelet transfusion refractoriness. Brit J Haematol. 2008 Jul.142(3):348-360. Pubmedid: 18510692.
    • Bradley MB, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G, Garvin J, George D, Bhatia M, Roman E, Baxter-Lowe LA, Schwartz J, Qualter E, Hawks R, Wolownik K, Foley S, Militano O, Leclere J, Cheung YK, Cairo MS. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant. 2007 Oct.40(7):621-631. Pubmedid: 17660841.
    • Shaz BH, Linenberger ML, Bandarenko N, Winters JL, Kim HC, Marques MB, Sarode R, Schwartz J, Weinstein R, Wirk A, Szczepiorkowski ZM. Category IV indications for therapeutic apheresis: ASFA fourth special issue. J Clin Apher. 2007 Jun.22(3):176-180. Pubmedid: 17377982.
    • Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2007 Jun.22(3):106-175. Pubmedid: 17394188.
    • Jhang JS, Schilsky ML, Lefkowitch JH, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher. 2007 Feb.22(1):10-14. Pubmedid: 17285615.
    • Jhang J, Middlesworth W, Shaw R, Charette K, Papa J, Jefferson R, Torloni AS, Schwartz J. Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation. J Clin Apher. 2007.22(6):333-338. Pubmedid: 18080271.
    • Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH, Savage DG. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology. 2006 Oct.67(8):1458-1460. Pubmedid: 16971696. Pmcid: PMC4345106.
    • Unal E, Yen C, Saiman L, George D, Della-Latta P, van de Ven C, Morris E, Bradley MB, Del Toro G, Garvin J, Bhatia M, Schwartz J, Satwani P, Roman E, Cooney E, Wolownik K, Hawks R, Foley S, Cairo MS. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Tr. 2006 Nov.12(11):1188-1197. Pubmedid: 17085312.
    • Schwartz J, Spitalnik S, Grima KM. Severe hemolysis following administration of Rh(o)(D) immune globulin in an ITP patient associated with anti-C. Blood. 2006 Mar.107(6):2585. Pubmedid: 16517982.
    • Zalsman G, Misgav S, Sommerfeld E, Kohn Y, Brunstein-Klomek A, Diller R, Sher L, Schwartz J, Shoval G, Ben-Dor DH, Wolovik L, Oquendo MA. Children's Depression Inventory (CDI) and the Children's Depression Rating Scale-Revised (CDRS-R): reliability of the Hebrew version. Int J Adolesc Med Health. 2005 Jul.17(3):255-257. Pubmedid: 16231477.
    • Nadav L, Schwartz J. [Self testing and self management of oral anticoagulants with warfarin]. Harefuah. 2003 Sep.142(8-9):621. Pubmedid: 14518167.
    • Gonzalez J, Palangio M, Fialkoff CN, Schwartz J, Bisaccia E. Giant congenital melanocytic nevus with a large ulceration at birth: a 5-year follow-up. J Am Acad Dermatol. 2003 Oct.49(4):752-754. Pubmedid: 14512935.
    • Schwartz J, Pinilla-Ibarz J, Yuan RR, Scheinberg DA. Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia. Semin Hematol. 2003 Jan.40(1):87-96. Pubmedid: 12563615.
    • Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 2003 Feb.72(2):94-98. Pubmedid: 12555211.
    • Eldor A, Schwartz J. Self-management of oral anticoagulants with a whole blood prothrombin-time monitor in elderly patients with atrial fibrillation. Pathophysiol Haemost Thromb. 2002 May.32(3):99-106. Pubmedid: 12372921.
    • Schwartz J, Eldor A, Szold A. Laparoscopic splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura. Arch Surg. 2001 Nov.136(11):1236-1238. Pubmedid: 11695964.
    • Gonzalez J, Palangio M, Schwartz J, Klainer AS, Bisaccia E. Scleromyxedema with dermato-neuro syndrome. J Am Acad Dermatol. 2000 May.42(5 Pt 2):927-928. Pubmedid: 10767707.
    • Schwartz J, Alster Y, Ben-Tal O, Lowenstein A. Visual loss following high-dose cytosine arabinoside (ARA-C). Eur J Haematol. 2000 Mar.64(3):208-209. Pubmedid: 10997890.
    • Szold A, Schwartz J, Abu-Abeid S, Bulvik S, Eldor A. Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: experience of sixty cases. Am J Hematol. 2000 Jan.63(1):7-10. Pubmedid: 10602160.
    • Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol. 2000 Aug.43(2 Pt 1):263-271. Pubmedid: 10906649.
    • Schwartz J, Gonzalez J, Palangio M, Klainer AS, Bisaccia E. Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study. Int J Dermatol. 1997 May.36(5):380-385. Pubmedid: 9199991.
    • Zimlichman R, Schwartz J, Tobar R. Rest and effort hemodynamic responses during prolonged treatment with felodipine, 24-h blood pressure monitoring, and echocardiographic changes. Am J Hypertens. 1997 Aug.10(8):905-912. Pubmedid: 9270086.
    • Schwartz J, Gonzalez J, Rosenberg R, Fujihara K, Cottrill CM, Klainer AS, Bisaccia E. Cutaneous T-cell lymphoma, tropical spastic paraparesis, cerebral vasculitis, and protein S deficiency in a patient with HTLV-I. South Med J. 1996 Oct.89(10):999-1000. Pubmedid: 8865796.
    • Gonzalez J, Berger C, Cottrill CM, Geller A, Schwartz J, Palangio M, Klainer AS, Bisaccia E. Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: preliminary study. Photochem Photobiol. 1996 May.63(5):558-561. Pubmedid: 8628744.
    • Anderson DR, Schwartz J, Cottrill CM, McClain SA, Ross JS, Magidson JG, Klainer A, Bisaccia E. Silicone granuloma in acral skin in a patient with silicone-gel breast implants and systemic sclerosis. Int J Dermatol. 1996 Jan.35(1):36-38. Pubmedid: 8838927.
    • Schwartz J, Gonzalez J, Cottrill CM, Magidson JG, Klainer A, Bisaccia E. Extracorporeal photochemotherapy in a patient with Ki-1-positive anaplastic large-cell lymphoma. Br J Dermatol. 1996 Feb.134(2):332-335. Pubmedid: 8746351.
    • Anderson DR, Schwartz J, Hunter NJ, Cottrill C, Bisaccia E, Klainer AS. Varicella hepatitis: a fatal case in a previously healthy, immunocompetent adult. Report of a case, autopsy, and review of the literature. Arch Intern Med. 1994 Sep.154(18):2101-2106. Pubmedid: 8092915.
    • Schwartz Y, Dolev E. [Osteoarticular tuberculosis in a general hospital]. Harefuah. 1991 Nov.121(10):357-359. Pubmedid: 1752548.
  • Patient Comments

    Overall Satisfaction

    0

    0 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey

     

    Comments

    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor